Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 3, 2013, Pages 1254-1263

  Borruel, Susana ^a,b   Fernández Durán, Elena ^a   Alpañés, Macarena ^a   Martí, David ^a   Álvarez Blasco, Francisco ^a   Luque Ramírez, Manuel ^a   Escobar Morreale, Héctor F ^a,c,d  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c HOSPITAL RAMÓN Y CAJAL   (Spain)

^d HOSPITAL CENTRAL DE LA DEFENSA GÓMEZ ULLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN;

ADOLESCENT; ADULT; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; CASE CONTROL STUDY; CONTROLLED STUDY; EPICARDIUM; FEMALE; HUMAN; HUMAN TISSUE; INTRAABDOMINAL FAT; LIPID STORAGE; MAJOR CLINICAL STUDY; MALE; MESENTERY; OBESITY; OVARY POLYCYSTIC DISEASE; PERITONEUM; PRIORITY JOURNAL; THICKNESS; ULTRASOUND;

ABDOMINAL FAT; ADIPOSITY; ADOLESCENT; ADULT; ANDROGENS; BODY FAT DISTRIBUTION; BODY MASS INDEX; CASE-CONTROL STUDIES; FATTY LIVER; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LIPIDS; MALE; PERITONEUM; POLYCYSTIC OVARY SYNDROME; SEX CHARACTERISTICS; VIRILISM; YOUNG ADULT;

EID: 84874890037     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3698     Document Type: Article

References (37)

1. Wells JC. Sexual dimorphism of body composition. Best Pract Res Clin Endocrinol Metab. 2007;21:415-430. (Pubitemid 47387103)
2. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Intern Med. 2005;165:777-783. (Pubitemid 40569431)
3. Escobar-Morreale HF, San Millan JL. Abdominal adiposity and the polycystic ovary syndrome. Trends Endocrinol Metab. 2007;18: 266-272. (Pubitemid 47332217)
4. Corton M, Botella-Carretero JI, Benguria A, et al. Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2007;92:328-337. (Pubitemid 46075011)
5. Corton M, Botella-Carretero JI, Lopez JA, et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod. 2008;23:651-661. (Pubitemid 351651200)
6. Pasquali R, Casimirri F, Cantobelli S, et al. Insulin and androgen relationships with abdominal body fat distribution in women with and without hyperandrogenism. Horm Res. 1993;39:179-187. (Pubitemid 23344790)
7. Barber TM, Golding SJ, Alvey C, et al. Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008;93:999-1004. (Pubitemid 351398585)
8. Oh JY, Lee JA, Lee H, Sung YA, Chung H. Serum C-reactive protein levels in normal-weight polycystic ovary syndrome. Korean J Intern Med. 2009;24:350-355.
9. Dolfing JG, Stassen CM, van Haard PM, Wolffenbuttel BH, Schweitzer DH. Comparison of MRI-assessed body fat content between lean women with polycystic ovary syndrome (PCOS) and matched controls: less visceral fat with PCOS. Hum Reprod. 2011;26:1495-1500.
10. Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96:E48- E56.
11. Battaglia C, Battaglia B, Mancini F, Paradisi R, Fabbri R, Venturoli S. Ultrasonographic extended-view technique for evaluation of abdominal fat distribution in lean women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2011;90:600-608.
12. Jones H, Sprung VS, Pugh CJ, et al. Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis, compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2012;97:3709-3716.
13. Cascella T, Palomba S, De Sio I, et al. Visceral fat is associated with cardiovascular risk inwomenwith polycystic ovary syndrome. Hum Reprod. 2008;23:153-159. (Pubitemid 351767326)
14. Karabulut A, Yaylali GF, Demirlenk S, Sevket O, Acun A. Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance. Gynecol Endocrinol. 2012;28:111-114.
15. Manneras-Holm L, Leonhardt H, Kullberg J, et al. Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance. J Clin Endocrinol Metab. 2011;96:E304-E311.
16. Penaforte FR, Japur CC, Diez-Garcia RW, Chiarello PG. Upper trunk fat assessment and its relationship with metabolic and biochemical variables and body fat in polycystic ovary syndrome. J Hum Nutr Diet. 2011;24:39-46.
17. Zawadzki JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens JR, Haseltine FP, Merriam GR, eds. Polycystic Ovary Syndrome. Boston: Blackwell Scientific Publications; 1992:377-384.
18. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
19. Azziz R, Carmina E, Dewailly D, et al. Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. J Clin Endocrinol Metab. 2006;91:4237-4245. (Pubitemid 44833391)
20. Escobar-Morreale HF, Sanchon R, San Millan JL. A prospective study of the prevalence of nonclassical congenital adrenal hyperplasia among women presenting with hyperandrogenic symptoms and signs. J Clin Endocrinol Metab. 2008;93:527-533. (Pubitemid 351240826)
21. Escobar-Morreale HF, Lasuncion MA, Sancho J. Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity. Fertil Steril. 2000;74:816-819.
22. Matsuda M, De Fronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-1470. (Pubitemid 29418240)
23. World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO Consultation. In: World Health Organization Monograph Series edition. WHO Technical Report, Series 894. Geneva: World Health Organization; 2000.
24. Liu KH, Chan YL, Chan WB, Kong WL, Kong MO, Chan JC. Sonographic measurement of mesenteric fat thickness is a good correlate with cardiovascular risk factors: comparison with subcutaneous and preperitoneal fat thickness, magnetic resonance imaging and anthropometric indexes. Int J Obes Relat Metab Disord. 2003;27: 1267-1273. (Pubitemid 37281676)
25. Ahn SG, Lim HS, Joe DY, et al. Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart. 2008;94:e7.
26. Saadeh S, Younossi ZM, Remer EM, et al. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology. 2002;123:745-750. (Pubitemid 34977081)
27. Insenser M, Montes-Nieto R, Vilarrasa N, et al. A nontargeted proteomic approach to the study of visceral and subcutaneous adipose tissue in human obesity. Mol Cell Endocrinol. 2012;363:10-19.
28. Martínez-García MÁ, Montes-Nieto R, Fernández-Durán E, Insenser M, Luque-Ramírez M, Escobar-Morreale HF. 2012 Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS) [published online ahead of print January 21, 2013]. J Clin Endocrinol Metab. doi:10.1210/jc.2012-3414.
29. Azziz R, Carmina E, Dewailly D, et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril. 2009;91:456-488.
30. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab. 2007;92:4546-4556. (Pubitemid 350223423)
31. Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AEPCOS) Society. J Clin Endocrinol Metab. 2010;95:2038-2049.
32. Escobar-Morreale HF, Samino S, Insenser M, et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem. 2012;58: 999-1009.
33. Vlachos IS, Hatziioannou A, Perelas A, Perrea DN. Sonographic assessment of regional adiposity. AJR Am J Roentgenol. 2007;189: 1545-1553. (Pubitemid 350174835)
34. Tornaghi G, Raiteri R, Pozzato C, et al. Anthropometric or ultrasonic measurements in assessment of visceral fat? A comparative study. Int J Obes Relat Metab Disord. 1994;18:771-775. (Pubitemid 24334523)
35. Pontiroli AE, Pizzocri P, Giacomelli M, et al. Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements. Obes Surg. 2002;12:648-651. (Pubitemid 35305743)
36. Abe T, Kawakami Y, Sugita M, Yoshikawa K, Fukunaga T. Use of B-mode ultrasound for visceral fat mass evaluation: comparisons with magnetic resonance imaging. Appl Human Sci. 1995;14:133-139.
37. Ma RC, Liu KH, Lam PM, et al. Sonographic measurement of mesenteric fat predicts presence of fatty liver among subjects with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011;96:799-807.